Literature DB >> 27025182

Changing oral vaccine to inactivated polio vaccine might increase mortality.

Eleanor N Fish1, Kate L Flanagan2, David Furman3, Sabra L Klein4, Tobias R Kollmann5, Dorthe L Jeppesen6, Ofer Levy7, Arnaud Marchant8, Siva Namachivayam9, Mihai G Netea10, Magdalena Plebanski11, Sarah L Rowland-Jones12, Liisa K Selin13, Frank Shann14, Hilton C Whittle15.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27025182      PMCID： PMC4922306          DOI： 10.1016/S0140-6736(16)00661-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges.

Authors:  Peter Aaby; Tobias R Kollmann; Christine Stabell Benn
Journal:  Nat Immunol       Date:  2014-10       Impact factor: 25.606

2.  Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: Observations from vaccination trials in Guinea-Bissau.

Authors:  Peter Aaby; May-Lill Garly; Jens Nielsen; Henrik Ravn; Cesario Martins; Carlitos Balé; Amabelia Rodrigues; Christine Stabell Benn; Ida Maria Lisse
Journal:  Pediatr Infect Dis J       Date:  2007-03       Impact factor: 2.129

3.  The Effect of Oral Polio Vaccine at Birth on Infant Mortality: A Randomized Trial.

Authors:  Najaaraq Lund; Andreas Andersen; Anna Sofie K Hansen; Frida S Jepsen; Amarildo Barbosa; Sofie Biering-Sørensen; Amabelia Rodrigues; Henrik Ravn; Peter Aaby; Christine Stabell Benn
Journal:  Clin Infect Dis       Date:  2015-07-28       Impact factor: 9.079
  3 in total
  9 in total

1.  The second coming: The comeback of the live vaccines.

Authors:  Anthony King
Journal:  EMBO Rep       Date:  2020-09-01       Impact factor: 8.807

2.  Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.

Authors:  Agustín Ciapponi; Ariel Bardach; Lucila Rey Ares; Demián Glujovsky; María Luisa Cafferata; Silvana Cesaroni; Aikant Bhatti
Journal:  Cochrane Database Syst Rev       Date:  2019-12-05

3.  Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine.

Authors:  Peter Aaby; Andreas Andersen; Cesário L Martins; Ane B Fisker; Amabelia Rodrigues; Hilton C Whittle; Christine S Benn
Journal:  BMJ Open       Date:  2016-12-23       Impact factor: 2.692

Review 4.  Neonatal Immunization: Rationale, Current State, and Future Prospects.

Authors:  Elizabeth Whittaker; David Goldblatt; Peter McIntyre; Ofer Levy
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

5.  Nonspecific Effects of Oral Polio Vaccine on Diarrheal Burden and Etiology Among Bangladeshi Infants.

Authors:  Alexander Upfill-Brown; Mami Taniuchi; James A Platts-Mills; Beth Kirkpatrick; Stacey L Burgess; M Steven Oberste; William Weldon; Eric Houpt; Rashidul Haque; K Zaman; William A Petri
Journal:  Clin Infect Dis       Date:  2017-08-01       Impact factor: 9.079

6.  A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage Malaria.

Authors:  Kirsty L Wilson; Dodie Pouniotis; Jennifer Hanley; Sue D Xiang; Charles Ma; Ross L Coppel; Magdalena Plebanski
Journal:  Front Immunol       Date:  2019-03-15       Impact factor: 7.561

7.  Nonspecific effects of oral vaccination with live-attenuated Salmonella Typhi strain Ty21a.

Authors:  S H Pennington; D M Ferreira; E Caamaño-Gutiérrez; J Reiné; C Hewitt; A D Hyder-Wright; S B Gordon; M A Gordon
Journal:  Sci Adv       Date:  2019-02-27       Impact factor: 14.136

Review 8.  Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development.

Authors:  Kathrin Balz; Lilith Trassl; Valerie Härtel; Philipp P Nelson; Chrysanthi Skevaki
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

9.  Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines.

Authors:  Mariusz Skwarczynski; Guangzu Zhao; Jennifer C Boer; Victoria Ozberk; Armira Azuar; Jazmina Gonzalez Cruz; Ashwini Kumar Giddam; Zeinab G Khalil; Manisha Pandey; Mohini A Shibu; Waleed M Hussein; Reshma J Nevagi; Michael R Batzloff; James W Wells; Robert J Capon; Magdalena Plebanski; Michael F Good; Istvan Toth
Journal:  Sci Adv       Date:  2020-01-29       Impact factor: 14.136
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.